A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to ...
which later won FDA approval for weight loss in 2023 under the brand name Zepbound. A similar version of this drug, called Mounjaro, has been available to people with type 2 diabetes since 2022.
James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...
Before the COVID pandemic, and the explosion in weight-loss drugs, the stock reached a peak ... Prior to being named CEO in 2022, Sistani was co-founder and CEO of Houseparty, a video chat app ...